Table 2.
Clinical Outcomes of the Patients, Stratified by the Change in the AQLQ Score after 4 Months.
| Characteristic | Responders | Non-responders | p value |
|---|---|---|---|
| n | 6 | 5 | |
| δACQ score (Baseline-at 4 months) | 1.2±1.11 | -0.2±0.60 | 0.03 |
| δFeNO level (ppb, at 4 months-baseline) | -48.7±47.02 | -6.33±20.46 | 0.14 |
| δblood eosinophil count (/µL, at 4 months-baseline) | -546.5±348.3 | -390.4±261.3 | 0.43 |
| δtotal serum IgE (IU/mL, at 4 months-baseline) | -54.83±45.73 | -92.0±167.2 | 0.61 |
| FEV1 (% predicted, at 4 months) | 79.73±13.84 | 79.42±24.66 | 0.98 |
| δFEV1 (% predicted, at 4 months-baseline) | 14.47±9.97 | 3.86±12.15 | 0.15 |
| FEV1 (L, at 4 months) | 1.81±0.60 | 1.54±0.64 | 0.48 |
| δFEV1 (L, at 4 months-baseline) | 0.35±0.33 | 0.05±0.21 | 0.11 |
Values are presented as mean±SD.
ACQ: Asthma Control Questionnaire, FEV1: forced expiratory volume in 1 s